Zymeworks Announces New Chair of Board of Directors and Voluntary Delisting from the TSX

Zymeworks Inc. (NYSE/TSX: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, announced that Lota Zoth has been appointed as its Chair of the Board of Directors.